<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Aberrantly expressed GFRα-1/RET in patients with lacrimal adenoid cystic carcinoma is associated with high recurrence risk: a retrospective study of 51 LACC cases.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Aberrantly expressed GFRα-1/RET in patients with lacrimal adenoid cystic carcinoma is associated with high recurrence risk: a retrospective study of 51 LACC cases." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/172c/7877180/2c9cfcfbc644/cbm-18-199-g002.jpg"/> </div> <div class="text-side"> <h1>Aberrantly expressed GFRα-1/RET in patients with lacrimal adenoid cystic carcinoma is associated with high recurrence risk: a retrospective study of 51 LACC cases.</h1> <p>The representative images of GDNF, GFRα-1 and RET expression detected by immunohistochemistry (IHC). A: Positive expression of GDNF in the non-basaloid type of LACC; B: Positive expression of GDNF in the basaloid type of LACC; C: Positive expression of GFRα-1 in the non-basaloid type of LACC; D: Positive expression of GFRα-1 in the basaloid type of LACC; E: Positive expression of Ret in the non-basaloid type of LACC; F: Positive expression of Ret in the basaloid type of LACC. A, B, D, F (IHC staining, 20 x); C, E (IHC staining, 40 x).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33628594/" target="_blank">33628594</a></p><p>Type: Premalignant/Malignant, Category: Adnexal</p>
</div> </div></div></body></html>